{"id":"carvedilol-controlled-release-lisinopril","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Dizziness"},{"rate":"5-15%","effect":"Fatigue"},{"rate":"5-10%","effect":"Cough"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"featherless-qwen","explanation":"Carvedilol, a non-selective beta-adrenergic receptor blocker, reduces heart rate and myocardial contractility, while lisinopril, an angiotensin-converting enzyme (ACE) inhibitor, blocks the conversion of angiotensin I to angiotensin II, leading to vasodilation and reduced blood pressure.","oneSentence":"Carvedilol controlled release/lisinopril combines a beta-blocker and an ACE inhibitor to reduce blood pressure and improve heart function.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:44:41.013Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypertension"},{"name":"Chronic heart failure"}]},"trialDetails":[{"nctId":"NCT00430040","phase":"PHASE4","title":"Vascular Benefits of Adding CarvedilolCR to Type2 Diabetic Patients on ACEI.","status":"TERMINATED","sponsor":"University at Buffalo","startDate":"2007-02","conditions":"Diabetes Mellitus, Type 2, Hypertension","enrollment":14},{"nctId":"NCT01009918","phase":"PHASE2","title":"Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab","status":"COMPLETED","sponsor":"University of South Florida","startDate":"2010-03","conditions":"Breast Cancer, Cardiac Toxicity","enrollment":468},{"nctId":"NCT00123903","phase":"PHASE3","title":"COREG MR Versus TOPROL-XL On Reduction Of Microalbuminuria In Patients With Hypertension And Microalbuminuria","status":"TERMINATED","sponsor":"GlaxoSmithKline","startDate":"2005-07","conditions":"Heart Failure, Congestive and Microalbuminuria","enrollment":1220},{"nctId":"NCT00624065","phase":"PHASE3","title":"Research Study To Test Carvedilol CR + Lisinopril Versus Lisinopril + Placebo In Patients With High Blood Pressure","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2008-03","conditions":"Hypertension","enrollment":348},{"nctId":"NCT00347360","phase":"PHASE3","title":"The COREG And Lisinopril Combination Therapy In Hypertensive Subjects (COSMOS) Trial","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2006-07","conditions":"Hypertension","enrollment":654},{"nctId":"NCT00108082","phase":"PHASE3","title":"The CLEVER Study - Coreg And Left Ventricular Mass Regression","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2005-01","conditions":"Hypertrophy, Left Ventricular","enrollment":287},{"nctId":"NCT00459056","phase":"PHASE3","title":"The Vascular Effects of Carvedilol Controlled Release (CR) in Abdominally Obese Hypertensive Patients","status":"COMPLETED","sponsor":"St. Paul Heart Clinic","startDate":"2007-04","conditions":"Abdominal Obesity, Hypertension","enrollment":25}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":5,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"carvedilol controlled release/lisinopril","genericName":"carvedilol controlled release/lisinopril","companyName":"GlaxoSmithKline","companyId":"gsk","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Carvedilol controlled release/lisinopril combines a beta-blocker and an ACE inhibitor to reduce blood pressure and improve heart function. Used for Hypertension, Chronic heart failure.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}